Immunome IMNM
NASDAQ IMNM
$26.75 -0.41 (-1.51%)
As of: Sep 4, 2026 · 3:59 PM EDT

Immunome (IMNM) FCF Margin (2023 - 2025)

Immunome's (IMNM) quarterly FCF Margin came in at 1171.18% in Q2 2025, down 1590.0% YoY from 78.6% in Q2 2024, and up 39.58% on a QoQ basis from 1938.48% in Q1 2025.

Analysis

Immunome (IMNM) FCF Margin (2023 - 2025) Analysis & Trends

Immunome (IMNM) has 3 years of FCF Margin data on file, last reported at 1171.18% in Q2 2025.

  • Quarterly FCF Margin fell 1590.0% year-over-year to 1171.18% in Q2 2025, while the trailing twelve-month figure through Mar 2026 was 5118.9% (down 362939.0% YoY) and the FY2025 annual result came in at 2890.13%, down 158533.0% from the prior year.
  • FCF Margin improved to 1171.18% in Q2 2025, from 1938.48% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 1013.11% in Q1 2023 to a low of 1938.48% in Q1 2025.
  • A 3-year average of 803.33% and a median of 1149.27% in 2024 frame the typical range for FCF Margin.
  • Annual changes were most pronounced in 2024 — FCF Margin plunged 215636 bps — and 2025, when it sank 1590 bps.
  • Tracing IMNM's FCF Margin over 3 years: stood at 457.81% in 2023, then sank by 245 bps to 1577.28% in 2024, then climbed by 26 bps to 1171.18% in 2025.
  • The last three FCF Margin figures came in at 1171.18% (Q2 2025), 1938.48% (Q1 2025), and 1577.28% (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 30.39%
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 13.35%
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -388.28%
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.68%
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 22.62%
8 Royalty Pharma 28.45 Bn 27.61 Bn - 70.82%
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -22.35%
10 Immunome 3.03 Bn 2.51 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -1,252.95%
Mar 31, 2025 -1,938.48%
Dec 31, 2024 -1,577.28%
Sep 30, 2024 -1,227.01%
Jun 30, 2024 -1,088.87%
Mar 31, 2024 -1,295.82%
Dec 31, 2023 -465.45%
Sep 30, 2023 -242.64%
Jun 30, 2023 -138.19%
Mar 31, 2023 1,013.11%